12 Health Care Stocks Moving In Tuesday's Pre-Market Session

+1.12% Pre

0.00% Pre

+2.57% Pre

-0.98% Pre

-2.28% Pre

ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS

ADXN

9.48

+1.12%

0.00% Pre

Acutus Medical

AFIB

0.00% Pre

Agape APT Corp.

ATPC

1.40

+2.57%

0.00% Pre

Cidara Therapeutics, Inc.

CDTX

48.30

-0.98%

0.00% Pre

Calidi Biotherapeutics, Inc. Common Stock

CLDI

0.24

-2.28%

0.00% Pre

Gainers

Agape ATP (NASDAQ:ATPC) shares rose 92.1% to $0.98 during Tuesday's pre-market session. The company's market cap stands at $75.5 million.
Jin Medical International (NASDAQ:ZJYL) stock moved upwards by 63.67% to $299.5. The company's market cap stands at $2.3 billion.
Iterum Therapeutics (NASDAQ:ITRM) stock increased by 60.89% to $2.88. The market value of their outstanding shares is at $38.6 million.
Motus GI Hldgs (NASDAQ:MOTS) stock rose 56.93% to $1.5. The market value of their outstanding shares is at $2.3 million.
Precision BioSciences (NASDAQ:DTIL) stock moved upwards by 16.88% to $0.45. The company's market cap stands at $54.8 million.
Cidara Therapeutics (NASDAQ:CDTX) stock rose 15.89% to $0.78. The company's market cap stands at $70.5 million.

Losers

60 Degrees (NASDAQ:SXTP) stock fell 30.9% to $0.36 during Tuesday's pre-market session. The company's market cap stands at $2.0 million.
CNS Pharma (NASDAQ:CNSP) shares declined by 21.64% to $0.26. The market value of their outstanding shares is at $1.6 million.
OneMedNet (NASDAQ:ONMD) stock declined by 21.17% to $1.08. The company's market cap stands at $34.8 million.
Addex Therapeutics (NASDAQ:ADXN) stock decreased by 16.04% to $11.0. The company's market cap stands at $12.3 million.
Calidi Biotherapeutics (AMEX:CLDI) shares decreased by 11.12% to $0.8. The market value of their outstanding shares is at $28.3 million.
Acutus Medical (NASDAQ:AFIB) stock decreased by 10.41% to $0.22. The market value of their outstanding shares is at $6.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.